Advanced search×

Cardiovascular disease in HIV infection.

Frank J FJ Palella and John P JP Phair

Curr Opin HIV AIDS 6(4):266-71 (2011) PMID 21546831

Highly active antiretroviral therapy (HAART) use has markedly reduced AIDS-related mortality and opportunistic illness. With improved survival, cardiovascular disease (CVD) has emerged as an important noninfectious chronic comorbidity among antiretroviral (ARV)-treated HIV-infected persons.

DOI: 10.1097/COH.0b013e328347876c
Version: za2963e q8za2 q8zb9 q8zc2 q8zdc q8ze3 q8zf2 q8zgc

Similar articles you may find interesting…

  1. Excess mortality in patients with AIDS in the era of highly active antiretroviral therapy: temporal changes and risk factors.
    Milo A MA Puhan, Mark L ML Van Natta, ...

    Clin Infect Dis 51(8):947-56 (2010) PMID 20825306

    We assessed temporal changes in excess mortality and elucidated risk factors for excess mortality in patients with AIDS diagnosed in the era of highly active antiretroviral therapy (HAART). Methods.  We included 1188 patients of the Longitudinal Study of Ocular Complications in AIDS who were aged...
  2. The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.
    Tammy M TM Rickabaugh, Ryan D RD Kilpatrick, ... Beth D BD Jamieson

    PLoS One 6(1):e16459 (2011) PMID 21298072 PMCID PMC3027697

    View PDF
  3. Fidelity of SNP array genotyping using Epstein Barr virus-transformed B-lymphocyte cell lines: implications for genome-wide association stud...
    Joshua T Herbeck, Geoffrey S Gottlieb, ... Philip Awadalla

    PLoS One 4(9):e6915 (2009) PMID 19730697 PMCID PMC2731852

    As availability of primary cells can be limited for genetic studies of human disease, lymphoblastoid cell lines (LCL) are common sources of genomic DNA. LCL are created in a transformation process that entails in vitro infection of human B-lymphocytes with the Epstein-Barr Virus (EBV).
    View PDF